3ERICO R,MARGHERITA Z,PAOLO V,et al.Raman and Solid State 13C-NMR Investigation of the Structure of the 1:1 Amorphous Piroxicam:β-Cyclodextrin Inclusion Compound[J].Biospectroscopy,1999,2:243-251.
4聂敏.吡罗昔康的不良反应.中国临床医药研究杂志,2003,3(9):92-92.
5BROGDEN R N, HEEL R C, SPEIGHT T M, et al. Piroxicam: a reappraisal of its pharmacology and therapeutic efficacy[J]. Drugs, 1984, 28:292- 323.
6Abdollahi Hamid, Sororaddin Mohammad Hossein. Naseri Abdolhossein. Simultaneous spectrofluorometric determination of piroxicam and pyridoxine using generalized rank annihilation method[J]. Analytical Sciences,2006,22 ( 2 ) : 263-267.
7DAMIANI P C, BEARZOTTI M, CABEZON M, et al. Spectrofluorometric determination of piroxicam [J]. Journal of Pharmaceutical and Biomedical Analysis, 1998, 17(2):233-236.
8ARANCIBIA J A, ESCANDAR G M. Two different strategies for the fluorimetric determination of piroxicam in scrum[J]. Talanta , 2003,60(6):1113-1121.
9GRACIELA M Escandar. Spectrofluorimetric determination of piroxicam in the presence and ab sence of β-cyclodextrin[J]. Analyst, 1999, 124:587-591.
